Low-level quantitation of oxycodone and its oxidative metabolites, noroxycodone, and oxymorphone, in rat plasma by high-performance liquid chromatography-electrospray ionization-tandem

被引:22
作者
Edwards, Stephen R. [1 ]
Smith, Maree T. [1 ]
机构
[1] Univ Queensland, Sch Pharm, Brisbane, Qld 4072, Australia
来源
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES | 2007年 / 848卷 / 02期
关键词
oxycodone; noroxycodone; oxymorphone; rat; high-performance liquid chromatography (HPLC); tlectrospray ionization (ESI); tandem mass spectrometry (MS-MS);
D O I
10.1016/j.jchromb.2006.10.039
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
A method was developed for quantification of oxycodone, noroxycodone, and oxymorphone in small volumes (50 W) of rat plasma by high-performance liquid chromatography-electrospray ionization-tandem mass spectrometry using turbo ion-spray. Deuterated (d(3)) opioid analogues acted as internal standards. Sample preparation involved protein precipitation with acetonitrile, centrifugal evaporation, and reconstitution in mobile phase; analyte separation was performed on a C 18 (5 mu m, 2.1 mm x 50 mm) column using a linear gradient program. Lower limits of quantitation (ng/ml) and their between-day accuracy and precision were-oxycodone, 0.9 (-0.2 and 7.8%); noroxycodone, 1.0 (0.6 and 6.2%); oxymorphone 1.0 (-1.8 and 9.5%). (c) 2006 Elsevier B.V. All rights reserved.
引用
收藏
页码:264 / 270
页数:7
相关论文
共 13 条
[1]   The use of liquid chromatography/mass spectrometry for quantitative analysis of oxycodone, oxymorphone and noroxycodone in Ringer solution, rat plasma and rat brain tissue [J].
Boström, E ;
Jansson, B ;
Hammarlund-Udenaes, M ;
Simonsson, USH .
RAPID COMMUNICATIONS IN MASS SPECTROMETRY, 2004, 18 (21) :2565-2576
[2]  
BOSTROM E, 2006, DRUG METAB DISPOS
[3]   Direct analysis of opiates in urine by liquid chromatography-tandem mass spectrometry [J].
Edinboro, LE ;
Backer, RC ;
Poklis, A .
JOURNAL OF ANALYTICAL TOXICOLOGY, 2005, 29 (07) :704-710
[4]   Simultaneous determination of morphine, oxycodone, morphine-3-glucuronide, and noroxycodone concentrations in rat serum by high performance liquid chromatography-electrospray ionization-tandem mass spectrometry [J].
Edwards, SR ;
Smith, MT .
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2005, 814 (02) :241-249
[5]   Effects of blocking CYP2D6 on the pharmacokinetics and pharmacodynamics of oxycodone [J].
Heiskanen, T ;
Olkkola, KT ;
Kalso, E .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1998, 64 (06) :603-611
[6]   Comparison of the pharmacokinetics of oxycodone and noroxycodone in male dark agouti and Sprague-Dawley rats: Influence of streptozotocin-induced diabetes [J].
Huang, L ;
Edwards, SR ;
Smith, MT .
PHARMACEUTICAL RESEARCH, 2005, 22 (09) :1489-1498
[7]   Pharmacokinetic-pharmacodynamic relationships of controlled-release oxycodone [J].
Kaiko, RF ;
Benziger, DP ;
Fitzmartin, RD ;
Burke, BE ;
Reder, RF ;
Goldenheim, PD .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1996, 59 (01) :52-61
[8]   Oxycodone [J].
Kalso, E .
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2005, 29 (05) :S47-S56
[9]   Quantitative contribution of CYP2D6 and CYP3A to oxycodone metabolism in human liver and intestinal microsomes [J].
Lalovic, B ;
Phillips, B ;
Risler, LL ;
Howald, W ;
Shen, DD .
DRUG METABOLISM AND DISPOSITION, 2004, 32 (04) :447-454
[10]   Pharmacokinetics and pharmacodynamics of oral oxycodone in healthy human subjects: Role of circulating active metabolites [J].
Lalovic, Bojan ;
Kharasch, Evan ;
Hoffer, Christine ;
Risler, Linda ;
Liu-Chen, Lee-Yuan ;
Shen, Danny D. .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2006, 79 (05) :461-479